This review identified limited evidence from 2 systematic reviews about the clinical effectiveness and safety of canakinumab for patients with adult-onset Still disease (AOSD). Most studies in on AOSD did not have a control group; therefore, findings related to this population are uncertain.
 For adults AOSD, treatment may be associated complete or partial response treatment, cortic...